Logo image of ZTEK

ZENTEK LTD (ZTEK) Stock Fundamental Analysis

NASDAQ:ZTEK - Nasdaq - CA98942X1024 - Common Stock - Currency: USD

1.21  +0.06 (+5.22%)

Fundamental Rating

2

Taking everything into account, ZTEK scores 2 out of 10 in our fundamental rating. ZTEK was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ZTEK has a bad profitability rating. Also its financial health evaluation is rather negative. ZTEK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZTEK had negative earnings in the past year.
ZTEK had a negative operating cash flow in the past year.
ZTEK had negative earnings in each of the past 5 years.
ZTEK had a negative operating cash flow in each of the past 5 years.
ZTEK Yearly Net Income VS EBIT VS OCF VS FCFZTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -56.02%, ZTEK is doing worse than 69.63% of the companies in the same industry.
The Return On Equity of ZTEK (-65.80%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -56.02%
ROE -65.8%
ROIC N/A
ROA(3y)-55.19%
ROA(5y)-53.21%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ZTEK Yearly ROA, ROE, ROICZTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZTEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZTEK Yearly Profit, Operating, Gross MarginsZTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K

More info and screens

3

2. Health

2.1 Basic Checks

ZTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZTEK has been increased compared to 1 year ago.
Compared to 5 years ago, ZTEK has more shares outstanding
Compared to 1 year ago, ZTEK has a worse debt to assets ratio.
ZTEK Yearly Shares OutstandingZTEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ZTEK Yearly Total Debt VS Total AssetsZTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 27.55 indicates that ZTEK is not in any danger for bankruptcy at the moment.
ZTEK has a Altman-Z score of 27.55. This is amongst the best in the industry. ZTEK outperforms 98.43% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ZTEK is not too dependend on debt financing.
ZTEK has a Debt to Equity ratio of 0.01. This is in the better half of the industry: ZTEK outperforms 69.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 27.55
ROIC/WACCN/A
WACC7.76%
ZTEK Yearly LT Debt VS Equity VS FCFZTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

ZTEK has a Current Ratio of 1.83. This is a normal value and indicates that ZTEK is financially healthy and should not expect problems in meeting its short term obligations.
ZTEK has a worse Current ratio (1.83) than 68.06% of its industry peers.
ZTEK has a Quick Ratio of 1.48. This is a normal value and indicates that ZTEK is financially healthy and should not expect problems in meeting its short term obligations.
ZTEK's Quick ratio of 1.48 is on the low side compared to the rest of the industry. ZTEK is outperformed by 60.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.48
ZTEK Yearly Current Assets VS Current LiabilitesZTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

ZTEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.61%, which is quite good.
The Revenue has grown by 92.56% in the past year. This is a very strong growth!
Measured over the past years, ZTEK shows a very strong growth in Revenue. The Revenue has been growing by 131.56% on average per year.
EPS 1Y (TTM)12.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.02%
Revenue 1Y (TTM)92.56%
Revenue growth 3Y131.56%
Revenue growth 5YN/A
Sales Q2Q%204.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZTEK Yearly Revenue VS EstimatesZTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M
ZTEK Yearly EPS VS EstimatesZTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZTEK Price Earnings VS Forward Price EarningsZTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZTEK Per share dataZTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENTEK LTD

NASDAQ:ZTEK (4/24/2025, 4:52:38 PM)

1.21

+0.06 (+5.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-23 2024-02-23/amc
Earnings (Next)N/A N/A
Inst Owners1.66%
Inst Owner Change0%
Ins Owners5.77%
Ins Owner ChangeN/A
Market Cap126.31M
Analysts84.44
Price TargetN/A
Short Float %0.15%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2700.34
P/FCF N/A
P/OCF N/A
P/B 10.79
P/tB 10.79
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.02%
ROE -65.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.19%
ROA(5y)-53.21%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.77%
Cap/Sales 218.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.48
Altman-Z 27.55
F-Score3
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)388.68%
Cap/Depr(5y)1741.19%
Cap/Sales(3y)2084.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.56%
Revenue growth 3Y131.56%
Revenue growth 5YN/A
Sales Q2Q%204.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.69%
OCF growth 3YN/A
OCF growth 5YN/A